Free Trial

VolitionRX (VNRX) SEC Filings & 10K Form

VolitionRX logo
$0.69 +0.01 (+1.16%)
As of 03:00 PM Eastern

Recent VolitionRX SEC Filings

DateFilerForm TypeView
08/15/2025
4:16 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 10-Q/A
08/14/2025
8:43 PM
ARMISTICE CAPITAL, LLC (Filed by)
VolitionRX (Subject)
VOLITIONRX LTD (Subject)
Form SCHEDULE 13G/A
08/06/2025
8:00 AM
Reynolds Cameron John (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025
8:00 AM
Innes Guy Archibald (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
3:01 PM
Rootsaert Rodney Gerard (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
3:01 PM
Forterre Gael (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
3:01 PM
Plummer Nicholas (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
3:01 PM
Batchelor Ann-Louise (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:01 PM
Reynolds Cameron John (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:01 PM
Hughes Terig (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
11:15 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form EFFECT
07/03/2025
1:17 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/03/2025
12:05 PM
Retter Andrew (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:05 PM
Butera Salvatore Thomas (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:05 PM
Batchelor Ann-Louise (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:05 PM
Forterre Gael (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:05 PM
Rootsaert Rodney Gerard (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:06 PM
Plummer Nicholas (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:27 AM
Reynolds Cameron John (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
6:55 AM
Innes Guy Archibald (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:05 PM
Hughes Terig (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Forterre Gael (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Butera Salvatore Thomas (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Rootsaert Rodney Gerard (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Michel Gaetan (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Plummer Nicholas (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Nguyen Kim (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:07 PM
Kway Jasmine (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
12:23 PM
Micallef Jacob Vincent (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
11:43 AM
Reynolds Cameron John (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
4:26 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
4:27 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2025
2:20 PM
ARMISTICE CAPITAL, LLC (Filed by)
VolitionRX (Subject)
VOLITIONRX LTD (Subject)
Form SCHEDULE 13G/A
04/22/2025
4:14 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 424B5
04/22/2025
4:16 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2025
11:15 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form EFFECT
04/16/2025
3:24 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form RW
04/15/2025
11:15 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form EFFECT
04/14/2025
8:39 AM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form S-3/A
04/04/2025
4:20 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/04/2025
4:22 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Silver’s Still Under $35… For Now. (Ad)

Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinking and demand surging from AI, EVs, and defense tech, this could be the most overlooked setup of 2025. Most investors haven’t caught on yet.tc pixel

Get the Silver Forecast before the breakout hits front-page news
03/27/2025
7:13 AM
Innes Guy Archibald (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
7:13 AM
Reynolds Cameron John (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:11 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
8:02 AM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 424B5
11/14/2024
3:24 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
3:23 PM
STILL TIMOTHY I (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/30/2024
3:38 PM
Rubin Ethel (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:21 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
3:29 PM
Rubin Ethel (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/27/2024
3:01 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSEAMERICAN:VNRX) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners